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Introdução: A Pneumonia de Aspiração é uma infeção respiratória 
aguda que decorre da entrada de fluídos e/ou alimentos com 
bactérias patogénicas para os pulmões. A sua prevalência 
aumenta com o envelhecimento e está correlacionada com 
doenças neurológicas, refluxo gastroesofágico e Doença 
Pulmonar Obstrutiva Crónica. Tem sido associada a elevadas 
taxas de reinternamento hospitalar, aumento da duração do 
internamento e da morbilidade e mortalidade, à diminuição da 
qualidade de vida e ao aumento dos custos de saúde. Alguns dos 
seus fatores de risco são modificáveis, por isso, torna-se essencial 
avaliar o efeito de intervenções preventivas para fundamentar a 
prática clínica. 
Objetivos: Rever estudos clínicos randomizados com foco no 
estudo de intervenções para prevenir a pneumonia de aspiração 
em pessoas idosas. 
Metodologia: Foi realizada uma revisão sistemática da literatura 
com base no protocolo registado no PROSPERO. Foram incluídos 
estudos clínicos randomizados de intervenções para reduzir a 
incidência de pneumonia de aspiração em indivíduos com mais de 
65 anos, publicados entre janeiro de 2002 e julho de 2019 e 
escritos em inglês. Estudos sobre pneumonia pós-cirúrgica foram 
excluídos. A qualidade metodológica dos estudos foi avaliada de 
forma independente por dois revisores utilizando a Cochrane 
Collaboration’s tool for assessing risk of bias. 
Resultados: Dos 629 artigos identificados, treze foram incluídos 
na revisão. Seis estudos analisaram intervenções farmacológicas, 
três artigos abordaram adaptações da dieta e estratégias 
compensatórias, um estudo avaliou uma técnica de higiene oral, 
dois estudaram intervenções multidisciplinares e um focou-se 
numa técnica de reabilitação. Dos estudos incluídos, cinco 
apresentaram efeito positivo na redução da incidência de 
pneumonia. A qualidade metodológica da generalidade dos 
estudos foi avaliada com risco de viés elevado ou indefinido. 
Conclusões: Os estudos mais recentes sobre intervenções para 
prevenir a pneumonia de aspiração em idosos revelaram 
qualidade metodológica pobre, dificultando a definição de 
orientações para a prática clínica. Dado o impacto negativo da 
pneumonia de aspiração nos doentes e nos sistemas de saúde, o 
desenvolvimento de estudos clínicos mais rigorosos é essencial. 
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Introduction: Aspiration Pneumonia is an acute respiratory 
infection that results from the entry of fluids (liquids, saliva, 
secretions) and/or food with pathogenic bacteria into the lungs. Its 
prevalence increases with aging and it is correlated with 
neurological diseases, gastroesophageal reflux and Chronic 
Obstructive Pulmonary Disease. Consequently, it has been 
significantly associated with high rates of hospital readmission, 
increased length of stay, morbidity and mortality, and with 
decreased quality of life and increased health costs. Some of its 
risk factors are modifiable, so it is essential to evaluate the effect 
of preventive interventions to support clinical practice. 
Objectives: To review randomised controlled trials focusing on the 
study of interventions to prevent aspiration pneumonia in older 
adults. 
Methodology: A systematic literature review was performed using 
the protocol registered in PROSPERO. Randomised controlled 
trials of interventions to reduce the incidence of aspiration 
pneumonia in individuals older than 65 years, published between 
January 2002 and July 2019 and written in English, were included. 
Studies on postoperative pneumonia were excluded. Two 
reviewers using the Cochrane Collaboration’s tool for assessing 
risk of bias independently assessed the methodological quality of 
the studies. 
Results: Of the 629 articles identified, thirteen met the eligibility 
criteria and were included in the review. Six studies analysed 
pharmacological interventions, three articles addressed dietary 
interventions and compensatory strategies, one study evaluated an 
oral hygiene technique, two studied the effect of multidisciplinary 
interventions and one focused on a rehabilitation technique. Of the 
included studies, five had a positive and statistically significant 
effect. The methodological quality of most studies was assessed at 
high or unclear overall risk of bias. 
Conclusions: The most recent studies on interventions to prevent 
aspiration pneumonia in the elderly revealed poor methodological 
quality, making it difficult to define evidence-based strategies for 
clinical practice. Given the burden of aspiration pneumonia on 
patients and healthcare systems, the development of more 
rigorous clinical trials is warranted.  
  
 
 
 
abreviations  
 
 
 
 
ASP – Aspiration pneumonia 
PRISMA - Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses 
PROSPERO - International Prospective Register of Systematic 
Reviews 
COPD – Chronic Obstructive Pulmonary Disease 
RCT – Randomized controlled trial 
CRCT – Cluster-randomized controlled trial  
OD – Oropharyngeal dysphagia 
ASU – Acute stroke unit 
EN – Enteral feeding 
NGT – Nasogastric tube 
PEG – Percutaneous endoscopic gastrostomy 
ACE – Angiotensin enzyme converting 
BHT - Chinese herbal medicine Banxia Houpu Tang 
SDD - Selective decontamination of the digestive tract  
QASC - Quality in Acute Stroke Care program 
UK – United Kingdom 
USA – United States of America 
NR – Not reported 
N/A – Not applicable 
SD – Standard deviation 
CT – Computed tomography  
CDT - Clostridium difficile toxin 
MRSA - Methicillin-resistant Staphylococcus aureus 
OR – Odds ratio 
HR – Hazard ratio 
CI – Confidence interval 
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1. INTRODUCTION 
Aspiration is reported to be a major etiological factor leading to pneumonia in the older 
population. It results of swallowing and cough-reflex impairments and it is significantly 
associated to dementia, cerebrovascular disease, Parkinson disease, Chronic 
obstructive pulmonary disease (COPD) and gastroesophageal reflux disease1–5.  
Aspiration Pneumonia (ASP) is a function-based category of pneumonia that is 
caused by the misdirection of fluids (liquids, saliva, secretions) or food with colonised 
pathogens into the lungs6–8. Its diagnosis is usually defined when there is radiological 
confirmation or a combination of valid clinical features of pneumonia with the 
simultaneous presence of risk factors and demonstrated or suspected aspiration. Three 
main risk factors that have been reported are: impaired safety of swallowing, which 
propels aspiration to the respiratory tract; impaired nutritional status, that is related with 
depressed immunologic responses; and poor oral health and hygiene, with respiratory 
pathogens colonised in the oral cavity9,10. Due to the lack of specific and rigorous markers 
of aspiration, ASP is frequently underdiagnosed11–14.  
Aspiration Pneumonia prevalence has been shown to increase with age and it is 
associated to high rates of hospital readmission, morbidity and in-hospital mortality, and 
to increased lengths of stay2,15–17.  
A recent longitudinal study conducted in acute care hospitals of the United States 
of America (USA) showed that between 2002 and 2012 the incidence rate of ASP was 
15 times higher in older patients than in patients aged younger than 65 years; the study 
also showed that the hospitalisation costs for ASP almost doubled during the study 
period15.  
Given the burden of ASP on patients, caregivers and the healthcare system and 
considering that some statistically significant risk factors for ASP are considered 
modifiable (e.g., dysphagia, dependency for feeding, dependency for oral care, feeding 
tube, weight loss, multiple medications, and impaired functional status) the importance 
of adopting preventive strategies to reduce ASP in older adults is clear and has been 
extensively reported3,7,15,17–19.  
In 2003, Loeb et al.20 systematically reviewed randomised controlled trials (RCT) 
which evaluated the effectiveness of preventive strategies for ASP in older people and 
concluded that clinical trial data available at the time was scarce. In their review, which 
included a total of eight studies, two of them were based on pharmacologic therapy and 
reported statistically significant risk reduction in pneumonia, but presented several 
adverse effects, including bleeding. One of the included studies had its focus on oral 
care, two investigated dietary interventions and compensatory strategies, and three 
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other articles studied enteral feeding. All of the included RCT were considered to have 
high risk of bias according to the authors definition20. To the best of our knowledge, there 
is no recent available update of this systematic review.  
The present article reports an updated systematic review of RCT that studied the 
effectiveness of pharmacologic and non-pharmacologic interventions to prevent 
aspiration pneumonia in older adults.  
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2. METHOD 
An update of an earlier systematic review20 was developed using a protocol registered 
on PROSPERO (CRD42019139973) and conducted according with Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.  
 
2.1 Eligibility Criteria 
The studies that were included had to focus on the effectiveness of single or multiple 
interventions to prevent ASP in patients aged 65 years or older, with reported 
oropharyngeal dysphagia (OD), previous stroke, previous aspiration, or tube feeding. All 
studies had to report incidence of pneumonia as primary or secondary outcome, 
diagnosed by chest X-ray or recognised clinical diagnostic criteria. Conference abstracts, 
letters to editor, case reports, case series, literature reviews, and trials on post-operative 
pneumonia were excluded. Because the previous systematic review20 analysed original 
RCT published until 2001, the literature search was restricted to articles with the same 
study design published since January 2002. Only articles written in English were 
included. 
 
2.2 Search Strategy 
The MEDLINE, Scopus and Web of Science databases, and the Cochrane Central 
Register of Controlled Trials were searched on July 23, 2019. Similar search strategies 
were used for all databases, combining Medical Subject Headings or free text words with 
the Boolean operators “AND/OR”. Search terms were “aspiration pneumonia”, 
“prevention and control”, “older adults”, “elderly”, “deglutition”, “swallowing”, “oral 
hygiene”, “compensatory strategy”, “positioning”, “pharmacologic therapy”, 
“rehabilitation”, “feeding”, “education”, “training”, “dietary intervention”, and “feeding 
tube”. Depending on the database, filters on years of publication, human trials, and study 
design were applied. 
 
2.3 Study Selection  
One of the reviewers (JS) performed the literature search and the screening of the results 
by title and abstract using broad inclusion and exclusion criteria. Screening decisions 
were checked by another reviewer (MM). Then, two reviewers (JS and MM) 
independently analysed full-text articles and decided on inclusion or exclusion by 
consensus. Disagreements were resolved through discussion and consensus reached 
with two additional reviewers (OR and LJ). 
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2.4 Data Synthesis 
One of the authors (JS) extracted data from the included articles and created summary 
tables with individual characteristics of the studies. Included studies’ findings were 
qualitatively analysed by intervention category and participants characteristics and the 
intervention effect was considered to be positive, negative or with no overall effect if the 
studies reported statistically significant decrease, increase or no effect in pneumonia 
incidence, respectively. This analysis was based on the statistical data provided by each 
study (Qui-square independence tests, logistic regressions and Kaplan-Meier survival 
analysis). Three reviewers (MM, OR and LJ) verified the accuracy of the data extraction 
and synthesis.  
 
2.5 Methodological Quality Assessment 
Two reviewers (JS and MM) independently assessed risk of bias for all included studies 
using Cochrane criteria21. Each domain was classified with low, high, or unclear risk of 
bias. Disagreements were discussed in a consensus meeting with two additional 
researchers (OR and LJ). Adequate follow-up was considered if 80% or more of the 
participants were still in the sample at the end of the study. 
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3. RESULTS 
3.1 Study Selection 
A total of 629 citations were found, 64 were assessed by full-text analysis and 13 met 
the eligibility criteria and thus included in the systematic review. Figure 1 provides a 
descriptive flow diagram of the selection process. The main reasons for exclusion of 
articles were related to study design (not RCT, abstracts and reviews), study population 
(paediatric, surgical patients and animals), objectives (treatment instead of preventive 
methods and prevalence studies), outcomes (other than pneumonia) and language the 
article was written in (not English). After the independent full-text study selection by two 
reviewers (JS and MM), different decision on eligibility was found in ten studies22–31. 
Thus, each one of them was analysed by two additional reviewers (OR and LJ) and 
discussed with all to reach consensus. Four of the discussed articles were excluded due 
to study design. Within the six included articles, four studies29–32 had defined 18 years 
as minimum age for study inclusion, but it was decided to include these articles since the 
mean ages of the participants were between 73 and 83 years and the majority of the 
participants in intervention and control groups of one study29 was older than 65 (69 and 
72%, respectively). Contact was attempted, with no success, with the authors of the other 
two discussed studies27,33 in order to ask for further information on the proportion of 
participants younger than 65 as they had not established eligibility criteria for age.  
 
3.2 Study Characteristics 
All included studies were RCT and two of them29,30 were randomised by cluster. The 
main settings of the included studies were acute stroke units (ASU), general hospitals 
and geriatric facilities. Regarding intervention category, six of the included studies26,30,33–
36 aimed to test pharmacologic interventions, three studies31,32,37 focused on dietary 
interventions or compensatory strategies, one study27 based its intervention in the use 
of a specific oral hygiene product, one study28 tested an intervention which combined 
both dietary intervention and oral hygiene, one study29 analysed the effectiveness of a 
multidisciplinary intervention, and one study38 focused on a rehabilitative technique. The 
overall characteristics of the included studies are presented in Table 1 and a descriptive 
summary of study components is provided in Table 2.  
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3.3 Participant Characteristics 
All the participants of included studies had some level of aspiration risk. Three 
studies27,29,30 included acute stroke patients, two studies32,34 focused on older patients 
with neurologic diseases (dementia, Parkinson’s disease and cerebrovascular disease), 
three studies26,28,38 recruited older adults with dysphagia, and five studies31,33,35–37 
included patients with need for enteral nutrition (EN). A wide range of sample sizes was 
Figure 1 – Flow diagram describing the study selection process, adapted from PRISMA. 
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observed throughout the included articles, ranging from 27 to 1126 participants. Two of 
the articles27,29 did not present means of age of participants and described their 
population in groups of age or using median values. In Middleton et al.29, the control and 
intervention groups younger than 65 years were composed of 28% and 31% of the 
participants, respectively; groups ranging from 65 to 74 years of age represented 26% 
and 24% of the sample (control and intervention); from 75 to 84 years of age, were 32% 
and 29%; and the groups aged 85 and older represented 15% and 16% of the total 
number of participants (control and intervention). Gosney et al.27 divided the participants 
in three groups, concerning the hospital where they were admitted, and the median 
values of age were between 62 and 78 years, with an age range from 16 to 96 years. 
Further descriptive data on the participants of the included studies is synthesized in 
Tables 1 and 2. 
 
SD, Standard deviation; RCT, Randomized controlled trial; CRCT, Cluster-randomized controlled trial; NR, Not reported; 
N/A, Not applicable; UK, United Kingdom; USA, United States of America. 
Table 1 - Characteristics of Included Studies (n=13) 
Study Design 
Country 
of origin 
Participants (n) Age, Mean (SD) Duration 
of follow-
up Intervention Control Intervention Control 
Gosney, 
200627 
RCT UK 103 100 NR NR 
8 and 15 
days 
Iwasaki, 
200734 
RCT Japan 44 48 84.5 (6.8) 
83.1 
(7.2) 
12 months 
Robbins, 
200832 
RCT USA 
Int. 1: 133 
Int. 2: 123 
Int. 3: 259 
N/A 
Int. 1: 80 
Int. 2: 81 
Int. 3: 81 
N/A 3 months 
Lee, 201037 RCT China 85 93 83.4 (9.4) 
83.2 
(9.9) 
1 month 
Middleton, 
201129 
CRCT Australia 626 500 NR NR 
90 days 
after ASU 
admission 
Nakashima, 
201126 
RCT Japan 
Imid.: 30 
Nicer.: 30 
N/A 
Imid.: 80.0 
Nicer.: 79.0 
N/A 6 months 
Takatori, 
201333 
RCT Japan 
Lans.: 41 
Mosa.: 38 
40 
Lans.: 85.0 
Mosa.: 82.5 
80.5 6 months 
Kalra, 201530 CRCT UK 615 602 77.7 (11.9) 
78.0 
(12.2) 
14 and 90 
days 
Lee, 201535 RCT China 33 38 83.4 (6.8) 
84.4 
(5.6) 
26 weeks 
Warusevitane, 
201536 
RCT UK 30 30 76.9 (6.3) 
79.2 
(10.8) 
21 days 
Fujimaki, 
201738 
RCT Japan 259 284 73.8 (7.5) 
73.9 
(7.0) 
6 months 
Higashiguchi, 
201728 
RCT Japan 109 143 88.3 (5.8) 
87.9 
(7.0) 
8 months 
Tabei, 201831 RCT Japan 15 12 82.7 (11.1) 
82.9 
(8.6) 
14 days 
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Study Participants Setting Intervention Comparison Primary outcomes 
Secondary 
outcomes 
Gosney, 200627 
Patients with first acute 
stroke, within the first 
24h of admission 
ASU of three 
hospitals 
Selective 
decontamination of the 
digestive tract with an 
oral gel 
Placebo 
Level of 
colonization of 
aerobic Gram-
negative bacteria 
(AGNB) 
Pneumonia 
Iwasaki, 200734 
Inpatients with diagnosis 
of cerebrovascular 
disease, Parkinson's 
disease or Alzheimer's 
disease, or various 
combinations of the 
three conditions 
Long-term care 
hospitals 
2.5 g of BHT two or 
three times a day, 
depending on patients’ 
body weight 
Placebo (1.0 g of 
lactose) 
Pneumonia and 
death-from 
pneumonia 
Number of febrile 
days and number of 
days during which a 
patient was treated 
with antibiotics 
Robbins, 200832 
Aged ≥ 50 years, with 
Dementia or Parkinson 
Disease, with suspected 
aspiration of liquids  
Acute and 
subacute care 
units 
Intervention 1: nectar-
thick liquids 
Intervention 2: honey-
thick liquids 
Chin-down posture 
Pneumonia 
(cumulative 
incidence rate) 
Death  
(cumulative 
incidence rate) 
Lee, 201037 
Aged ≥ 60 years, who 
were likely to require 
nasogastric tube feeding 
for at least 4 weeks 
Three 
convalescence 
hospitals and 1 
infirmary 
Continuous pump 
feeding 
Intermittent bolus 
feeding by gravity 
Pneumonia Death 
Middleton, 201129 
Aged ≥ 18 years, with 
diagnosis of ischemic 
stroke or intracerebral 
haemorrhage, within 48h 
of onset of symptoms 
ASU 
Fever, Sugar and 
Swallowing Intervention 
(FeSS) 
Abridged version of 
existing guidelines 
Death or 
dependency, 
functional 
dependency, mean 
SF-36 mental 
component 
summary score, 
and mean physical 
component 
summary score 
Mean temperature 
and mean finger-
prick blood glucose 
for the first 72h after 
ASU admission, 
proportion with 
swallowing 
screening 
undertaken within 
the first 24h of ASU 
admission, 
discharge diagnosis 
of aspiration 
pneumonia and 
length of hospital 
stay 
Table 2 – Summary of Study Components 
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Nakashima, 201126 
Aged ≥ 65 years, with 
history of pneumonia 
within the previous 2 
years and presence of 
dysphagia 
General hospital 
Imidapril group: 5mg of 
imidapril daily 
Nicergoline group: 
15mg of nicergoline 
daily 
Serum levels of 
substance P 
Pneumonia 
recurrence 
Takatori, 201333 
Patients with dysphagia 
who required 
gastrostomy feeding 
Geriatric hospitals 
and nursing 
facilities 
Lansoprazole group: 
15mg lansoprazole 
once a day via PEG 
tube before morning 
meal;  
Mosapride group: 5mg 
of mosapride citrate 3 
times a day via PEG 
tube before each meal 
No medication Pneumonia 
Days of fever and 
days of vomiting 
Kalra, 201530 
Aged ≥ 18 years, with 
confirmed diagnosis of 
acute stroke, with onset 
of symptoms within 48h 
at recruitment, and failed 
bedside swallow test or 
presence of nasogastric 
tube 
Stroke units 
Prophylactic antibiotics 
for 7 days plus standard 
stroke unit care 
Standard stroke unit 
care 
Pneumonia 
Death at 14 and 90 
days, functional 
status at 90 days, 
length of stay, CDT-
positive diarrhoea, 
MRSA colonization, 
health-related quality 
of life (EuroQoL) 
Lee, 201535 
Tube-fed patients, aged 
≥ 60 years, with history 
of recent hospitalization 
in the previous 3 
months, and that had 
been on tube-feeding for 
more than 2 weeks 
because of neurologic 
dysphagia, with clinical 
diagnosis of 
cerebrovascular 
diseases 
Acute university 
medical wards, 
subacute 
hospitals, affiliated 
geriatric outpatient 
clinics and speech 
therapy clinics 
Lisinopril 2,5mg once 
daily at bedtime 
Placebo 
Pneumonia  
(incidence rate) 
Death and fatal 
pneumonia  
(incidence rates) 
Warusevitane, 
201536 
Patients within 7 days of 
acute ischemic or 
haemorrhagic stroke 
confirmed by CT scan, 
who required NGT for 
>24 hours, and could be 
ASU 
10 mg metoclopramide 
(10 mL), 3 times daily 
via the NGT 
Placebo (10 mL normal 
saline) 
Pneumonia 
Witnessed 
aspiration, highest 
levels of white blood 
cell count and C-
reactive protein, the 
lowest oxygen 
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recruited within 48 hours 
of NGT insertion 
saturation, the 
number of antibiotic 
days, neurological 
deficits, swallow 
improved and NGT 
removed/referral for 
PEG 
Fujimaki, 201738 
Patients aged ≥ 60 
years, complaining of 
aspiration or 
hoarseness/dysphonia 
caused by glottal 
incompetence, and 
endoscopically 
confirmed 
General hospitals 
Self-controlled vocal 
exercise guided by a 
DVD 
Control patients were 
given an informative 
brochure with 
explanations and 
recommendations 
Maximum 
phonation time 
Hospitalizations with 
pneumonia 
Higashiguchi, 201728 
Patients at risk for 
aspiration pneumonia, 
aged ≥ 75 years, BMI < 
18.5kg/m2, serum 
albumin level ≤ 3.5g/dL, 
with dysphagia but had 
capacity for oral food 
intake, with thickening 
agent for drinks 
1: intensive care 
home for the older 
people; 2: nursing 
care facility for 
older people; 3: 
rehabilitation 
hospital 
Oral care intervention 
(wiping) and oral 
nutritional supplements 
(ONS) 
Conventional oral care 
and diet 
Pneumonia 
Body weight, crural 
circumference, mean 
daily caloric intake 
and blood 
biochemistry 
parameters 
Tabei, 201831 
Aged ≥ 20 years, who 
needed nutritional 
therapy intervention 
because oral intake was 
not possible for any 
reason, who received 
EN management limited 
to the stomach 
General hospitals 
Viscosity-regulating 
pectin solution 
administered as a bolus 
using a syringe in 
patients before the 
administration of the 
liquid EN diet 
Liquid EN diet 
administered to 
patients based on the 
conventional method in 
each participating 
institution 
Pneumonia, fever 
over 37.5˚C and 
vomiting 
Onset of diarrhoea, 
infusion period (time) 
ASU, Acute Stroke Unit; CDT, Clostridium difficile toxin; MRSA, methicillin-resistant Staphylococcus aureus; PEG, Percutaneous endoscopic gastrostomy; SF-36 Health Survey; NGT, Nasogastric 
tube; EN, Enteral nutrition. 
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3.4 Summary of Findings  
Table 3 summarises reported data on the effectiveness of the interventions of all included 
studies. 
 
3.4.1 Pharmacologic Therapy 
Six studies26,30,33–36 focused on pharmacologic therapy interventions, in which three 
studies33,35,36 addressed older adults who required EN, and other three studies26,30,34 
enrolled older patients with neurologic disease (stroke, dementia or Parkinson’s 
disease).  
Regarding the first three articles33,35,36, one study36 evaluated the effect of regular 
treatment with metoclopramide (10mg; three times daily) on the incidence of pneumonia 
in nasogastric tube (NGT)-fed patients. The results showed a significant decrease of 
pneumonia in the intervention group when compared to the placebo group (OR, 5.24; 
p<0.001). Regarding mortality, there were also fewer deaths in metoclopramide group, 
but no statistically significant effect was attained (OR, 1.85; p=0.292). Diarrhoea was the 
most common side-effect within the participants (20% in the placebo group and 30% in 
the intervention group; p=0.371). Other study33 assessed the therapeutic effect of 
mosapride citrate and lansoprazole on the prevention of ASP in patients receiving 
percutaneous endoscopic gastrostomy (PEG) feeding, based on the premises that the 
anti-reflux effect of mosapride and the lowering of intragastric acidity and fluid volume 
powered by lansoprazole might prevent ASP in these patients. The study results showed 
a significant reduction of pneumonia in the mosapride group when compared with control 
(p=0.038) and lansoprazole (p=0.005) groups. The authors33 did not provide statistical 
analysis of the comparison between lansoprazole and control groups; and no adverse 
effects were reported. Another RCT35 was conducted in order to assess if angiotensin 
enzyme converting (ACE) inhibitors (lisinopril; 2.5mg/day) reduce the incidence of 
pneumonia in tube-fed frail older patients with severe dysphagia due to cerebrovascular 
disease. The study results showed similarly high incidence of pneumonia in both ACE 
inhibitor and control groups (p=0.390); and higher mortality rate in the intervention group 
participants (OR 7.79; p=0.018). 
Within the other three articles, one study34 analysed the effectiveness of the 
traditional Chinese herbal medicine Banxia Houpu Tang (BHT) for preventing ASP and 
pneumonia-related mortality in older adults; and the study findings pointed to significantly 
lower rate of pneumonia in BHT group as compared with control group (p=0.008). No 
adverse events were observed among the study participants. A second study26 
compared the effects of nicergoline (5mg/day) on serum substance P, dysphagia and 
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pneumonia recurrence with the effects of imidapril (15mg/day) in older adults with 
dysphagia and previous history of pneumonia, but there was no statistically significant 
difference in the pneumonia recurrence between both interventions. Neither of the 
groups presented side-effects during the trial period. A third study30 aimed to assess the 
effectiveness of prophylactic antibiotics for reducing pneumonia and mortality in patients 
with dysphagia after acute stroke; and its results revealed no significant differences in 
both outcomes between the groups (pneumonia OR 1.21, p=0.489; mortality OR 0.95, 
p=0.796).  
 
3.4.2 Dietary Intervention and Compensatory Strategy 
Two studies31,32 analysed the effect on pneumonia of interventions based on the 
adaptation of food consistencies and one study37 compared the effectiveness of two 
different formula delivery modes among tube-fed older patients. Other study28 used oral 
nutrition supplementation as part of an oral hygiene intervention and it is approached in 
Multidisciplinary Intervention category.  
Robbins et al.32 performed a 3-month RCT to compare the effectiveness of chin-
down posture and two consistencies of thickened liquids on the cumulative incidence 
rate of pneumonia in older patients with dementia or Parkinson’s disease. The results 
showed no statistically significant differences in the survival analysis between the 
thickened liquid and chin-down groups, and neither between nectar-thick and honey-
thick liquid groups (Table 3). The main adverse events experienced by the participants 
were dehydration, urinary tract infection and fever, and their incidence was higher in the 
thickened liquids groups than in the chin-down group.  
Two studies31,37 conducted RCT focused on compensatory strategies for older 
patients who required EN. Lee et al.37 compared the effect on pneumonia from two 
formula delivery modes (intermittent bolus feeding by gravity and continuous pump 
feeding) and the results showed no statistically significant differences in pneumonia and 
mortality between groups. The authors37 reported no adverse events. Tabei et al.31 
assessed the effectiveness of a viscosity-regulating pectin solution in EN management 
when compared with the conventional liquid EN diet administration. No significant 
differences were observed regarding pneumonia between the two groups, as none of 
the participants presented pneumonia during the study period. Likewise, no adverse 
events were observed. 
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3.4.3 Oral Hygiene 
Two studies27,28 explored oral care interventions and one of them combined oral hygiene 
with nutritional supplementation, so it is described below in the category of 
Multidisciplinary Intervention. In 2006, Gosney et al.27 conducted a RCT to investigate 
the effectiveness of selective decontamination of the digestive tract (SDD) with a specific 
oral gel on the morbidity and mortality of patients with acute stroke. The study was 
developed in the ASU of three hospitals in England, included 100 patients for the 
intervention group and 103 for control and follow-up assessments were made at days 8 
and 15. The study results suggested a positive and statistically significant effect of SDD 
intervention in reducing the incidence of pneumonia in acute stroke patients (p=0.029). 
In what concerned mortality, 11% of the deaths were in the control group and 9% in the 
intervention group, but the authors failed to report data on the statistical significance of 
these results. No adverse events associated to this intervention were reported. 
 
3.4.4 Multidisciplinary intervention 
Two articles addressed multidisciplinary interventions. One study28 evaluated the 
effectiveness of a combined care intervention, which was composed of oral hygiene and 
oral nutritional supplements, on the incidence of pneumonia in adults aged 75 or older. 
Intervention consisted in providing oral care intervention (wiping) and oral nutritional 
supplements in addition to the usual oral care and diet of the participating facilities. The 
results of the study showed no statistically significant differences in the incidence of 
pneumonia at follow-up, although it was higher in the control group than in the 
intervention group (p=0.056). The authors pointed out the significantly higher prevalence 
of swallowing dysfunction at baseline in the intervention group (p=0.009) as a possible 
constraint to the demonstration of significance on the expected outcome. However, the 
results showed a significant increase in the body weight of the intervention group and 
the authors underlined this as an important aspect for further study regarding the 
prevention of sarcopenia in older adults. No adverse events associated to the 
intervention were reported. 
Another study29 reported the implementation of the Quality in Acute Stroke Care 
(QASC) program in a cluster-randomised controlled trial that aimed to assess the effect 
of multidisciplinary team building workshops and a standardised education program to 
implement evidence-based treatment protocols on the management of fever, 
hyperglycaemia and swallowing dysfunction in acute stroke patients. Regarding 
swallowing, nurses had to successfully complete an education program on dysphagia 
screening and all patients admitted for acute stroke had to be screened for dysphagia 
14 
 
within the first 24 hours. Patients who failed the swallowing screening were referred to a 
speech pathologist for clinical assessment. At follow-up, no statistically significant 
differences were found in the prevalence of ASP between intervention and control groups 
(p=0.82). However, patients in the intervention group were significantly more likely to be 
alive and independent at the end of the study period (p=0.002). Given these results, the 
authors underlined the importance of multidisciplinary triage and early intervention in 
acute stroke patients for the reduction of rates of death and dependency and for the 
improvement of processes of care. 
 
3.4.5 Rehabilitative interventions 
One six-month RCT38 was conducted to assess the effectiveness of a self-controlled 
vocal exercise on the incidence of pneumonia in older patients with physiological glottal 
closure. The authors reported statistically significant differences between the 
intervention and the control groups regarding the incidence of hospitalisations with 
pneumonia (0.77 and 6.34%, respectively; p<0.001). During the clinical trial period, three 
participants presented hyperadduction of the false vocal folds as an adverse effect of the 
intervention, but it was resolved in all subjects with exercise performance correction38. 
Since vocal function significantly improved in the intervention group and the incidence of 
pneumonia was significantly lower than in control group, authors suggested that this new 
technique might be a cost-effective method for preventing pneumonia in older adults with 
presbyphonia. 
 
3.5 Methodological Quality 
Based on the Cochrane Collaboration's tool for assessing risk of bias21, one study35 was 
considered to have low overall risk of bias, three articles27,37,38 were classified with high 
overall risk of bias, and the remaining nine studies26,28–34,36 raised doubts about one or 
more domains and therefore were considered as having unclear overall risk of bias. The 
degree of agreement between the two reviewers on the risk of bias assessment ranged 
from 61.5 to 100%.  
Regarding follow-up, all the studies had over 80% of the participants at the end 
of the study period and were considered to have adequate follow-up, except for three 
studies28,35,38.  
The consensus decisions on the methodological quality and follow-up adequacy 
of the included studies are presented in Table 4. 
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Study 
Pneumonia 
P-value Effect 
Death 
P-value Adverse effects 
Intervention Control Intervention Control 
Gosney, 200627 0.97% 7% 0.029 + 8.74% 11% NR NR 
Iwasaki, 200734 9.1% 29.20% 0.008 + RR 0.41 (95% CI 0.10, 1.03) a 0.06 None 
Robbins, 200832 
HR 0.84 (95% CI 
0.49, 1.45) b 
HR 0.50 (95% CI 
0.23, 1.09) c 
N/A 
0.530 b 
0.083 c 
<> 
HR 0.98 (95% CI 
0.65, 1.48) d 
HR 0.76 (95% CI 
0.43, 1.36) e 
N/A 
0.940 d 
0.360 e 
Dehydration, urinary 
tract infection, fever * 
Lee, 201037 14.10% 15.10% NR <> 8.20% 14.0% 0.226 NR 
Middleton, 201129 2.16% 2.69% 0.820 <> 24.78% 38.59% 0.020 NR 
Nakashima, 201126 
Imid.: 30% 
Nicer.: 17% 
N/A NR <> NR N/A NR None 
Takatori, 201333 
Lans.: 49% 
Mosa.: 18% 
40% 0.038 f + NR NR NR NR 
Kalra, 201530 OR 1.21 (95% CI 0.71, 2.08) g 0.489 <> OR 0.95 (95% CI 0.62, 1.44) h 0.796 
Non-post-stroke 
pneumonia infections 
(p=0.02) ** 
Lee, 201535 57.60% 47.40% 0.390 <> OR 7.79 (95% CI 1.42, 42.65) i  0.020 NR 
Warusevitane, 201536 OR 5.24 (95% CI 2.43, 11.27) j <0.001 + OR 1.85 (95% CI 0.59, 5.80) k 0.292 Diarrhoea 
Fujimaki, 201738 0.77% 6.34% <0.001 + NR NR NR 
Hyperadduction of the 
false vocal folds 
Higashiguchi, 201728 7.8% 17.7% 0.056 <> NR NR NR NR 
Tabei, 201831 0 0 N/A N/A NR NR NR None 
OR, Odds Ratio; CI, Confidence interval; NR, Not reported; N/A, Not applicable; Effect: (+) positive effect, (<>) no effect, (-) negative effect; a Relative risk of death from pneumonia adjusted for facility; 
b Results from the 3-month Kaplan-Meier estimates of pneumonia in the chin-down posture and thickened-liquid groups; c Results from the 3-month Kaplan-Meier estimates of pneumonia in the nectar-
thick and honey-thick liquid groups; d Results from the 3-month Kaplan-Meier estimates of pneumonia or death in the chin-down posture and thickened-liquid groups; e Results from the 3-month Kaplan-
Meier estimates of pneumonia or death in the nectar-thick and honey-thick liquid groups; f Control vs. Mosapride; g Results from odds ratio of post-stroke pneumonia at 14 days, adjusted for patient, 
stroke, and centre characteristics; h Results from odds ratio of all-cause mortality at 14 days; i Results from odds ratio of 6-month mortality, adjusted for all baseline characteristics of Intervention and 
Placebo Groups; j Results from the between-group rate ratio of pneumonia, adjusted for age and baseline National Institutes for Health Stroke Scale score and expressed with the placebo group as 
the reference group; k Results from the between-group rate ratio of deaths, adjusted for age and baseline National Institutes for Health Stroke Scale score and expressed with the placebo group as 
the reference group; * The combined outcome of at least 1 dehydration, urinary tract infection, or fever event was significantly more frequent in the thickened-liquid groups than the chin-down posture 
group (p=0,055); ** Intervention group had a significantly lower number of non-post-stroke pneumonia infections compared with control. 
Table 3 – Effectiveness of Interventions Described in the Included Studies 
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Follow-up: (+) adequate; (-) inadequate; NR, not reported. 
 
Table 4 – Methodological Quality of the Included Studies 
Study 
Random 
Sequence 
Generation 
Allocation 
Concealment 
Selective 
Reporting 
Other 
bias 
Blinding 
Incomplete 
outcome data 
Overall risk of 
bias (within 
studies) 
Follow-up 
Participants 
and personnel 
Outcome 
assessors 
Gosney, 200627 low unclear high unclear unclear unclear high high + 
Iwasaki, 200734 low unclear low unclear unclear Low unclear unclear + 
Robbins, 200832 low low unclear unclear unclear unclear low unclear + 
Lee, 201037 low unclear unclear unclear unclear High unclear high + 
Middleton, 201129 low low low Low unclear Low low unclear + 
Nakashima, 201126 low low low unclear unclear Low low unclear + 
Takatori, 201333 low unclear unclear unclear unclear unclear low unclear + 
Kalra, 201530 low low unclear Low low Low low unclear + 
Lee, 201535 low low low Low low Low low low - 
Warusevitane, 
201536 
low low Low Low unclear Low low unclear + 
Fujimaki, 201738 low unclear Low unclear unclear High unclear high - 
Higashiguchi, 
201728 
low unclear Unclear unclear unclear unclear unclear unclear NR 
Tabei, 201831 unclear unclear Low unclear unclear unclear low unclear + 
% of agreement 
attained between 
reviewers’ 
judgements 
100 69.23 61.54 84.62 69.23 100 76.92  
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4. DISCUSSION 
The aim of this review was to provide the most updated evidence on the effects of 
healthcare interventions to reduce ASP in older adults. Regarding the intervention types, 
six studies26,30,33–36 were focused on pharmacologic therapies, three articles31,32,37 studied 
dietary interventions and compensatory strategies, one27 explored an oral hygiene 
intervention, two28,29 analysed multidisciplinary approaches, and one38 analysed a 
rehabilitative intervention. Five31,33,35–37 studies analysed patients with need for EN, three 
articles27,29,30 studied individuals with acute stroke, another three26,28,38 focused on older 
adults with OD and risk of ASP, and two studies32,34 considered older patients with 
neurodegenerative diseases. There was a wide range of sample sizes and of trial 
duration periods, but most studies presented small sample sizes and short-term 
intervention periods. As expected, the heterogeneity of the included studies did not 
enable a quantitative assessment of the effects. 
 In what concerned pharmacologic interventions, three studies33,34,36 showed 
positive and statistically significant effects on pneumonia incidence. One RCT36 analysed 
the use of metoclopramide in NGT-fed patients, another article33 studied the effect of 
mosapride citrate in patients with PEG feeding and another study34 assessed the effect 
of the traditional Chinese medicine BHT. However, the same three studies were 
considered as having unclear overall risk of bias, and considering the small sample sizes 
used, their results may not be generalisable to the population.  
 Regarding dietary interventions and compensatory strategies, none of the 
included studies31,32,37 showed significant effect on the prevention of ASP. The use of 
thickened liquids, which is frequently recommended in clinical practice, remains poorly 
supported by RCT and one of the included studies32 revealed that the thickened liquid 
group presented higher prevalence of dehydration, fever and urinary tract infections than 
the chin-down posture group. Thus, these effects must be considered when making 
decisions on the best feeding consistency for the patients at risk for ASP. 
 One unexpected result was the inclusion of only one RCT27 with focus on oral 
care interventions, given the extensive scientific evidence supporting poor oral health as 
a key risk factor for developing ASP12,17,39. This study showed a statistically significant 
reduction on ASP incidence in patients with acute stroke with the use of an SDD gel. 
However, it was considered to have weak methodological quality and high overall risk of 
bias which might have led to overestimated results. 
 Two studies28,29 on multidisciplinary interventions failed to demonstrate 
statistically significant effects on the prevention of ASP. Nevertheless, one RCT29 
showed positive effects on mortality and functionality of patients in the intervention group 
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which reinforced the importance of multidisciplinary interventions to improve healthcare 
services. Another study28 revealed significant positive effects on body weight of the 
intervention group participants and the authors underlined the potential of such 
intervention to reduce sarcopenia in older adults. 
 In what concerns rehabilitative interventions, one RCT38 met the inclusion criteria 
of this review and showed positive and statistically significant effect of a self-controlled 
vocal exercise on ASP incidence. This intervention was presented as a cost-effective 
technique to prevent ASP and its side-effects were shown to be reversible. In what 
regards to the study’s methodological quality, it was considered to have high overall risk 
of bias mainly due to the unblinding of outcome assessors. 
 Of all included studies, only one RCT35 was considered as having low overall risk 
of bias, but its results showed no significant effect in the prevention of ASP. The 
pharmacologic intervention the study considered was based on the daily administration 
of lisinopril to tube-fed stroke patients and revealed statistically significant reduction in 
the mortality of the intervention group when compared to control group (placebo). 
 Comparing the current review findings with those of the previous systematic 
review20, there was an increase in the number of RCT conducted about this topic, since 
it included a total of eight articles. Regarding the intervention types, two studies were 
focused on pharmacologic interventions, other two on dietary interventions and 
compensatory strategies, one article assessed an oral hygiene method, and three RCT 
analysed the effects of EN. In what concerned participants phenotypes, the previous 
review included four studies focused on older patients with stroke or other neurologic 
disease, two were limited to hospitalised patients receiving EN, and one studied only 
nursing home residents. Four studies showed positive effect in reducing ASP, however, 
all the included studies presented weak methodological quality and were classified as at 
high risk of bias. Most studies in the previous review had small sample sizes as in the 
present review, but the duration of the interventions was wider, ranging from 7 days to 
three years. The main results of the review20 led the authors to conclude that none of the 
interventions were likely to be widespread accepted in clinical practice, considering that 
some presented gastrointestinal and neurological side-effects and bleeding. Also, it was 
underlined the necessity to develop more well-designed clinical trials on this subject. 
 
4.1 Study limitations and implications for practice 
The main limitations of the present review regard the eligibility criteria (inclusion of 
studies with some participants younger than 65 years) preestablished in the review 
protocol, and to the achievement of modest overall inter-rater agreement in the 
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methodological assessment. Despite the Cochrane Collaboration’s tool for assessing 
risk of bias being recognised as a useful and valid instrument to address main sources 
of bias in RCT and to identify studies that may exaggerate treatment effects, some 
evaluation studies40,41 have reported that it also allows substantial variation in agreement 
between assessors across domains. Similarly to these studies results, selective 
reporting was the domain with the slightest inter-rater agreement40,41. 
Due to weak methodological quality across studies, small sample sizes, and the 
specific characteristics of the participants and the review limitations, it was not possible 
to draw solid conclusions on the effectiveness of the interventions reviewed for the 
prevention of ASP.  
 
4.2 Future work 
During the study selection, many of the identified studies that focused on the prevention 
of ASP were excluded because of study design (n=31). Also, there were promising 
results on the preventive effect of  three pharmacologic interventions33,3 
4,36, which lead to the need for developing more and larger RCT on this subject. 
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5. CONCLUSIONS 
Aspiration pneumonia is highly prevalent in the older population, even though it is 
frequently underdiagnosed. The increase of life expectancy, the high prevalence of 
chronic diseases in older adults and the consequent increase of functional dependency, 
make older people more vulnerable for developing ASP and increase the need for 
specialized healthcare services. Consequently, it increases the responsibilities of 
healthcare providers on its management. Thus, considering the negative impact of ASP 
in the quality of life of older patients, their families and on the sustainability of healthcare 
systems, the need to provide guidelines for better clinical practice is warranted8,42–44.  
The present Thesis aimed to review the most updated evidence on ASP 
prevention; however, in the absence of large well-designed trials with positive effects on 
the reduction of ASP, it is not possible to point out effective strategies that could be 
generalised to a specific population. Thus, the necessity of developing larger and higher-
quality RCT to assess preventive interventions for ASP (already identified in 2003 by the 
authors of the previous review20), remains current.  
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Review question
What is the effectiveness of pharmacologic therapies, rehabilitation techniques, compensatory
strategies/positioning changes, dietary interventions, educational programs, oral hygiene and tube feeding
for prevention of aspiration pneumonia in older adults?
 
Searches
The search will be performed using the following databases: MEDLINE (PubMed), Cochrane Library, Scopus
and Web of Science. The search terms will include the Medical Subject Heading (MeSH Terms) “aspiration
pneumonia” with the qualifier “prevention and control” combined with the free-text words “older adults”,
“elderly”, “deglutition”, “oral hygiene”, “compensatory strategy”, “positioning”, “pharmacologic therapy”,
“rehabilitation”, “feeding”, “education”, “training”, “dietary intervention” and “feeding tube”. Only articles
written in English and published from January 2002 to June 2019 will be included.
 
Types of study to be included
Only original randomised controlled trials (RCTs) designed to assess the effectiveness of single or multiple
interventions for prevention of aspiration pneumonia will be included in the review. Articles must include
aspiration pneumonia as primary outcome, as well as sufficient information on study design, characteristics
of participants and interventions provided to be eligible. Studies of postoperative aspiration pneumonia will
be excluded.
 
Condition or domain being studied
Single and multiple interventions for prevention of aspiration pneumonia. Eligible studies must refer
radiological confirmation of pneumonia or any recognised diagnostic criteria.
 
Participants/population
Patients aged 65 and older who were at risk for aspiration pneumonia. This will be based on documented
oropharyngeal dysphagia, previous stroke, previous aspiration, or tube feeding.
 
Intervention(s), exposure(s)
All original RCTs that study the effectiveness of single or multiple prevention programs for aspiration
pneumonia will be included.
 
Comparator(s)/control
Interventions must include a comparison with placebo, no intervention (usual care), or another type of
intervention.
 
Context
Contexts to be considered include hospitals; rehabilitation centres; nursing homes and geriatric long term
care facilities.
 
Main outcome(s)
The main outcome is the incidence of pneumonia within the trial period. Pneumonia must be diagnosed
using chest radiography or any recognised clinical criteria.
Timing and effect measures
Included studies must report the incidence of pneumonia from baseline until the final follow-up. Data analysis
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of such studies must include valid statistical methods that enable comparisons between groups.
 
Additional outcome(s)
Secondary outcomes will address the incidence of aspiration, mortality, changes in body weight and
functional outcome according to a standardised scale during the intervention period. All adverse effects
resulting from such interventions will be analysed.
Timing and effect measures
Included studies must report secondary outcomes and adverse effects observed from baseline until the final
follow-up. Data analysis of such studies must include valid statistical methods that enable comparisons
between groups.
 
Data extraction (selection and coding)
Two reviewers (JS and MM) will independently perform the initial selection of studies based on title and
abstract. Full-text of the articles obtained in the initial phase will be analysed by the same reviewers, who will
independently select eligible articles for inclusion in the review. Disagreement will be resolved through
discussion and consensus with two additional reviewers (LJ and OR). The process of study selection will be
documented in a flow chart, as recommended by the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) statement (Moher et al., 2009). After the selection phase, one reviewer (JS) will
extract data on study design, demographics, intervention, study validity and effect measurement from all
included articles. The extracted data will be checked by three researchers (MM, LJ and OR). The reviewers
will contact the authors in case of missing data or additional details. An Excel spreadsheet will be created for
the registry of the search strategy and its results, as well as to record the decisions made in each selection
phase and the data extracted. Reference: Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting
items for systematic reviews and meta-analyses: the PRISMA statement. Journal of Clinical Epidemiology
2009;62(10):1006–12.
 
Risk of bias (quality) assessment
Study validity will be independently assessed by two reviewers (JS and MM) according to The Cochrane
Collaboration's tool for assessing risk of bias (Higgins et al., 2011). Adequate follow-up will be considered if
80% or more of the participants are still in the sample at the end of the study. Reference: Higgins Julian P T,
Altman Douglas G, Gøtzsche Peter C, Jüni Peter, Moher David, Oxman Andrew D et al. The Cochrane
Collaboration’s tool for assessing risk of bias in randomised trials BMJ 2011; 343: d5928
 
Strategy for data synthesis
Due to the expected heterogeneity between interventions, data analysis will be qualitative. Thus,
interventions will be classified as having positive, negative or no overall effect on the primary outcome
depending on whether a significant difference in AP between groups is demonstrated. Data synthesis will be
organised in a Summary of Findings table as recommended in Chapter 11 of the Cochrane Handbook for
Systematic Reviews of Interventions, including information on participant demographics, methodological
quality and intervention methods and effect (Schünemann et al., 2011). Reference: Schünemann HJ, Oxman
AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and ‘Summary of findings'
tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions
Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from
www.handbook.cochrane.org.
 
Analysis of subgroups or subsets
The results for each trial will be grouped by intervention category (dietary interventions and compensatory
strategy, pharmacologic therapies, oral hygiene, feeding tube and training and education) and, if the
necessary data are available, by pathology (e.g. stroke, dementia).
 
Contact details for further information
Joana Santos
santosjoana@ua.pt
 
Organisational affiliation of the review
School of Health, University of Aveiro (ESSUA)
https://www.ua.pt/essua/#
 
                               Page: 2 / 4
PROSPERO
International prospective register of systematic reviews
Review team members and their organisational affiliations
Ms Joana Santos. University of Aveiro
Professor Óscar Ribeiro. University of Aveiro, Department of Education and Psychology (DEP), and
CINTESIS – Center for Health Technology and Services Research (CINTESIS.UA), Portugal.
Professor Luis Jesus. University of Aveiro, School of Health (ESSUA), and Institute of Electronics and
Informatics Engineering of Aveiro (IEETA), Portugal.
Professor Maria Matos. University of Aveiro, School of Health (ESSUA), Portugal
 
Type and method of review
Prevention, Systematic review
 
Anticipated or actual start date
01 July 2019
 
Anticipated completion date
01 October 2019
 
Funding sources/sponsors
None
 
Conflicts of interest
 
Language
English
 
Country
Portugal
 
Stage of review
Review Ongoing
 
Subject index terms status
Subject indexing assigned by CRD
 
Subject index terms
Humans; Pneumonia, Aspiration; Risk Factors
 
Date of registration in PROSPERO
30 September 2019
 
Date of publication of this version
30 September 2019
 
Details of any existing review of the same topic by the same authors
 
Stage of review at time of this submission
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Preliminary searches No No
Piloting of the study selection process Yes No
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Data extraction No No
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